Home

Dr Reddys Laboratories PE Ratio

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

PE

18.2

Last updated on: May 06, 2025

Key Highlights

  • The P/E Ratio of Dr Reddys Laboratories Ltd is 18.2 as of 06 May 15:30 PM .
  • The P/E Ratio of Dr Reddys Laboratories Ltd changed from 25.6 on March 2020 to 18.4 on March 2024 . This represents a CAGR of -6.39% over 5 years.
  • The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1159 as of 06 May 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 39.9 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 39.9. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Dr Reddys Laboratories Ltd

No data available

Company Fundamentals for Dr Reddys Laboratories Ltd

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

Share Price

₹ 1159.9

-12.60 (-1.07%)

stock direction

Last updated on: May 06, 2025

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 May 20251159.9
05 May 20251172.5
02 May 20251182.9
30 Apr 20251183
29 Apr 20251176.25
28 Apr 20251199.7
25 Apr 20251173.55
24 Apr 20251201.45
23 Apr 20251185.95
22 Apr 20251174.85

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Dr Reddys Laboratories Ltd

Asset Value vs Market Value of Dr Reddys Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Dr Reddys Laboratories Ltd97839
Sun Pharmaceutical Industries Ltd440314
Divis Laboratories Ltd162809
Cipla Ltd124627
Torrent Pharmaceuticals Ltd111122
Mankind Pharma Ltd99679

PE Ratio of Dr Reddys Laboratories Ltd Explained

97839

Market cap

5371

Earnings

18.2X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Dr Reddys Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Dr Reddys Laboratories Ltd

No data available

* All values are in %

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

Dr Reddys Laboratories Ltd News Hub

Dr Reddys Laboratories Ltd gains for third straight session

Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 707

Read more

21 Aug 24

Dr Reddy's formulations manufacturing units receives EIR from USFDA

Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) for its formulations m

Read more

12 Aug 24

Dr Reddys allots 29,790 equity shares under ESOP

Dr Reddys Laboratories has allotted 29,790 equity shares of Rs.5/- each underlying 29,790 ADRs pursu

Read more

07 Aug 24

Dr Reddy's Labs Andhra Pradesh facility gets EIR from USFDA

The inspection has been classified as voluntary action indicated (VAI) and has been closed according

Read more

06 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Dr Reddys Laboratories Ltd

What is the current PE Ratio of Dr Reddys Laboratories Ltd?

The Current PE Ratio of Dr Reddys Laboratories Ltd is 18.22 as on 6 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 39.9 as on 6 May 2025.

What was the PE Ratio of Dr Reddys Laboratories Ltd last year?

The PE Ratio of Dr Reddys Laboratories Ltd was 17.08 last year, now the PE ratio is 18.22, showing a year-on-year growth of 6.7%.

What does the PE Ratio of Dr Reddys Laboratories Ltd indicate about its stock?

The PE Ratio of Dr Reddys Laboratories Ltd is 18.22. This ratio indicates that investors are willing to pay 18.22 times the earnings per share for each share of Dr Reddys Laboratories Ltd.

What is the PE Ratio Growth of Dr Reddys Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Dr Reddys Laboratories Ltd grew by 6.7% whereas, the EPS ratio grew by -77.5.

How does the PE ratio of Dr Reddys Laboratories Ltd compare to industry peers?

The PE ratio of Dr Reddys Laboratories Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Dr Reddys Laboratories Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Dr Reddys Laboratories Ltd PE Ratio.

What factors influence the PE ratio of Dr Reddys Laboratories Ltd PE Ratio?

The PE ratio of Dr Reddys Laboratories Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Dr Reddys Laboratories Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Dr Reddys Laboratories Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Dr Reddys Laboratories Ltd PE Ratio?

You can check the latest PE ratio of Dr Reddys Laboratories Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Dr Reddys Laboratories Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Dr Reddys Laboratories Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Dr Reddys Laboratories Ltd PE Ratio predict future stock performance?

While the Dr Reddys Laboratories Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions